IHS Chemical Week

World News and Views :: Projects

DSM Divests Biologics Plant; Focuses on Cell Technology

1:29 PM MDT | July 31, 2007 | Alex Scott

DSM says it has sold its biologic drugs plant at Montreal to AstraZeneca for an undisclosed sum. The Montreal facility was DSM’s only commercial manufacturing plant for biologic drugs. The company says it plans to focus its biologics activities on developing manufacturing technologies and services. Staal: Change of strategy for biologics. DSM says it mothballed the Montreal plant in December 2005 due to a lack of orders for products from the facility. DSM says it will book a “small profit” from the divestment but it declined to provide...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa